News

Skin cancer is the most common cancer in the United States, with an estimated 1 in 5 Americans developing skin cancer in their lifetime. This summer season, Megan McNally, MD, a fellowship-trained surgical oncologist with Saint Luke's Cancer Institute, joined KCTV to share helpful insights on skin safety.

A recent study led by Andrew Sauer, M.D., cardiologist at Saint Luke’s Mid America Heart Institute, showed that for patients with heart failure, hospital participation in the IMPLEMENT-HF initiative improves patient care.

After receiving care at Saint Luke's and relearning how to walk through rigorous outpatient rehab, Michelle returned to Saint Luke's to visit with her care team.

After a fainting spell, Angela Alvarez was ultimately diagnosed with cardiomyopathy and congestive heart failure. Her original plan of action was to undergo a heart transplant, but she sought a second opinion at Saint Luke’s Mid America Heart Institute.

A local man with heart failure who was told numerous times he only had months to live gets a second chance at life after treatment at Saint Luke's.

When Debbie O’Neal was diagnosed with heart failure at 75, she feared her life was ending. She was the same age that her mother had been when she died of heart disease.

Ahead of American Heart Month, USA Today talks with Dr. James O’Keefe of the Saint Luke’s Mid America Heart Institute about five steps you can take to reduce your risk of developing heart disease.

According to a new study, higher omega-3 levels significantly reduce the risk of heart failure and heart failure fatalities.

A potassium binder helped patients with heart failure who have or are at high risk for hyperkalemia stay on spironolactone at an optimal dose, but showed a signal of HF hospitalization risk.

A secondary analysis of the pooled STEP-HFpEF and STEP-HFpEF DM trials showed the greatest improvements in those with the most weight loss at 52 weeks.